These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 35991619)

  • 1. Neuromodulation devices for heart failure
    Dusi V; Angelini F; Zile MR; De Ferrari GM
    Eur Heart J Suppl; 2022 Sep; 24(Suppl E):E12-E27. PubMed ID: 35991619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-pharmacologic autonomic neuromodulation for treatment of heart failure: A systematic review and meta-analysis of randomized controlled trials.
    Ahmed M; Nudy M; Bussa R; Weigel F; Naccarelli G; Maheshwari A
    Trends Cardiovasc Med; 2024 Feb; 34(2):101-107. PubMed ID: 36202286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NEUROMODULATION OF THE FAILING HEART: LOST IN TRANSLATION?
    Byku M; Mann DL
    JACC Basic Transl Sci; 2016 Apr; 1(3):95-106. PubMed ID: 27525317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and future use of neuromodulation in heart failure
    Duncker D; Bauersachs J
    Eur Heart J Suppl; 2022 Sep; 24(Suppl E):E28-E34. PubMed ID: 35991620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updates on Baroreflex Activation Therapy and Vagus Nerve Stimulation for Treatment of Heart Failure With Reduced Ejection Fraction.
    Babar N; Giedrimiene D
    Cardiol Res; 2022 Feb; 13(1):11-17. PubMed ID: 35211219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vagal stimulation in heart failure.
    Dusi V; De Ferrari GM
    Herz; 2021 Dec; 46(6):541-549. PubMed ID: 34716778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantation of a vagus nerve stimulator for patients with heart failure with reduced ejection fraction: An educational video.
    Al Rameni D; Akay M; Jumean M; Al Rameeni A; Kar B; Gregoric ID
    JTCVS Tech; 2022 Aug; 14():96-98. PubMed ID: 35967202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vagal Neuromodulation in Chronic Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta-Analysis.
    Sant'Anna LB; Couceiro SLM; Ferreira EA; Sant'Anna MB; Cardoso PR; Mesquita ET; Sant'Anna GM; Sant'Anna FM
    Front Cardiovasc Med; 2021; 8():766676. PubMed ID: 34901227
    [No Abstract]   [Full Text] [Related]  

  • 9. Multifactorial Benefits of Chronic Vagus Nerve Stimulation on Autonomic Function and Cardiac Electrical Stability in Heart Failure Patients With Reduced Ejection Fraction.
    Verrier RL; Libbus I; Nearing BD; KenKnight BH
    Front Physiol; 2022; 13():855756. PubMed ID: 35431984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Device-Based Solutions to Improve Cardiac Physiology and Hemodynamics in Heart Failure With Preserved Ejection Fraction.
    Rosalia L; Ozturk C; Shoar S; Fan Y; Malone G; Cheema FH; Conway C; Byrne RA; Duffy GP; Malone A; Roche ET; Hameed A
    JACC Basic Transl Sci; 2021; 6(9-10):772-795. PubMed ID: 34754993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Denervation or stimulation? Role of sympatho-vagal imbalance in HFpEF with hypertension.
    Nagai M; Dote K; Förster CY
    Hypertens Res; 2023 Jul; 46(7):1727-1737. PubMed ID: 37045971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Our Clinical Understanding of Autonomic Regulation Therapy Using Vagal Nerve Stimulation in Patients Living With Heart Failure.
    Konstam MA; Mann DL; Udelson JJE; Ardell JL; De Ferrari GM; Cowie MR; Klein HU; Gregory DD; Massaro JM; Libbus I; DiCarlo LA; Butler J; Parker JD; Teerlink JR
    Front Physiol; 2022; 13():857538. PubMed ID: 35530511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep and future insights into neuromodulation therapies for heart failure.
    Kishi T
    J Cardiol; 2016 Nov; 68(5):368-372. PubMed ID: 27293020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction.
    Zile MR; Lindenfeld J; Weaver FA; Zannad F; Galle E; Rogers T; Abraham WT
    J Am Coll Cardiol; 2020 Jul; 76(1):1-13. PubMed ID: 32616150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Device Autonomic Regulation Therapy in Patients with Heart Failure with Reduced Ejection Fraction.
    N Williford N; Statz G; L Mann D; Olshansky B
    J Atr Fibrillation; 2020; 13(1):2409. PubMed ID: 33024509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent Autonomic Engagement and Cardiac Control After Four or More Years of Autonomic Regulation Therapy Using Vagus Nerve Stimulation.
    Libbus I; Premchand RK; Sharma K; Mittal S; Monteiro R; Amurthur B; KenKnight BH; DiCarlo LA; Anand IS
    Front Physiol; 2022; 13():853617. PubMed ID: 35360224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromodulation for the Treatment of Heart Rhythm Disorders.
    Waldron NH; Fudim M; Mathew JP; Piccini JP
    JACC Basic Transl Sci; 2019 Aug; 4(4):546-562. PubMed ID: 31468010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromodulation Approaches for Cardiac Arrhythmias: Recent Advances.
    Dusi V; Zhu C; Ajijola OA
    Curr Cardiol Rep; 2019 Mar; 21(5):32. PubMed ID: 30887264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventional and device-based autonomic modulation in heart failure.
    Shen MJ; Zipes DP
    Heart Fail Clin; 2015 Apr; 11(2):337-48. PubMed ID: 25834979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vagus nerve stimulation for the treatment of heart failure].
    De Ferrari GM; Dusi V
    G Ital Cardiol (Rome); 2015 Mar; 16(3):147-54. PubMed ID: 25837458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.